Bayer reported €29.4B in Current Liabilities for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Akzo Nobel AKZA:NA € 4869M 462M
Alcon AG ALC:SW 2.47B 97M
Arkema AKE:FP € 1993M 46M
AstraZeneca AZN:LN 22594M 1055M
BASF BAS:GR € 20322M 788M
Bayer BAYN:GR € 29403M 676M
Covestro 1COV:GR 3.61B 443M
Genmab GEN:DC DK 1339M 229M
Givaudan GIVN:VX 2.32B 96M
GRIFOLS GRF:SM € 1921.48M 360.62M
Hikma Pharmaceutical HIK:LN 1.02B 56M
Johnson Matthey JMAT:LN 3.58B 21M
Linde LIN:GR € 13643M 1115M
Lonza Group LONN:SW 2.37B 739M
Novartis NOVN:VX SF 30208M 328M
SAP SAP:GR € 16050M 1539M
Solvay SOLB:BB € 5531M 857M
Umicore UMI:BB 3.48B 524M